Newsgather

LSE

Stable1000 articles17 sourcesDernière mise à jour: il y a 24 minutes

Derniers articles

Novo Nordisk Sues Eli Lilly Over 'Misleading' Weight-Loss Drug Ads
En développement
Business·il y a 2 heuresRésumé IA

Novo Nordisk Sues Eli Lilly Over 'Misleading' Weight-Loss Drug Ads

Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.

G
Guardian Business
1 min de lecture
Unapproved Ovarian Cancer Blood Test Available in Australia Sparks Expert Concern
En développement
Santé·il y a 3 heuresRésumé IA

Unapproved Ovarian Cancer Blood Test Available in Australia Sparks Expert Concern

An "early detection blood test" for ovarian cancer is now available in Australia for $1,495, marketed by BCAL Diagnostics. Despite ads targeting all women, the company states it's for high-risk individuals. Experts warn the test is not TGA-approved, has limited data, and a significant false-positive rate, potentially causing distress and unnecessary costs.

G
Guardian Australia
4 min de lecture
런던증권거래소, 내년 상반기부터 야간 거래소 신설…24시간 거래 추진
En développement
Business·il y a 13 heuresRésumé IA

런던증권거래소, 내년 상반기부터 야간 거래소 신설…24시간 거래 추진

런던증권거래소(LSE)가 내년 상반기부터 거의 24시간 운영되는 야간 거래소 'LSE 24'를 신설할 계획이라고 21일 밝혔다. 이는 암호화폐 거래소와의 경쟁 심화와 아시아 개인 투자자 유치를 위한 움직임으로, 나스닥과 CME도 거래시간을 연장하고 있다.

연합뉴스
1 min de lecture